ArticleThoracic cancer2016

Irinotecan plus fluorouracil-based regimen as second or third-line chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma.

Xi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.